When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - FDA OKs Celgene's fedratinib for myelofibrosis
Bristol-Myers Squibb Company
Under Priority Review status, FDA approves Celgene's (CELG+0.6%) Inrebic (fedratinib) for the treatment of a bone marrow disorder called intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocytopenia) myelofibrosis.
More news on: Celgene Corporation, Incyte Corporation, Bristol-Myers Squibb Company, Healthcare stocks news,